Gene · 7398
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An integrated proteomic portrait of prostate cancer progression. | Cell Rep | 2025 | 40517382 | PubTator, text mining | PubMed |
| The advancement of ubiquitination regulation in apoptosis, ferroptosis, autophagy, drug resistance and treatment of cancer. | Arch Biochem Biophys | 2025 | 40499632 | PubTator, text mining | PubMed |
| An archaeal nucleoid-associated protein binds an essential motif in DNA replication origins. | Nat Commun | 2025 | 40473630 | PubTator, text mining | PubMed |
| Cutting-edge AI tools revolutionizing scientific research in life sciences. | BioTechnologia (Pozn) | 2025 | 40401131 | PubTator, text mining | PubMed |
| Editor's Note: Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells. | Clin Cancer Res | 2025 | 40370044 | PubTator, text mining | PubMed |
| Assessing Supraspinatus Tendon Elasticity at Different Locations and Loading Conditions Using Ultrasound Shear-Wave Elastography in Young Healthy Population. | Diagnostics (Basel) | 2025 | 40361950 | PubTator, text mining | PubMed |
| USP1 inhibition: A journey from target discovery to clinical translation. | Pharmacol Ther | 2025 | 40274197 | PubTator, text mining | PubMed |
| Harnessing the Deubiquitinase USP1 for Targeted Protein Stabilization. | J Am Chem Soc | 2025 | 40252079 | PubTator, text mining | PubMed |
| LncRNA OLMALINC promotes osteosarcoma progression through USP1-mediated autophagy suppression. | Hum Cell | 2025 | 40249458 | PubTator, text mining | PubMed |
| Emerging frontiers in protein structure prediction following the AlphaFold revolution. | J R Soc Interface | 2025 | 40233800 | PubTator, text mining | PubMed |
| Comprehensive interrogation of synthetic lethality in the DNA damage response. | Nature | 2025 | 40205037 | PubTator, text mining | PubMed |
| Exosome-transmitted HSPA9 facilitates bortezomib resistance by targeting TRIP13/USP1 signaling in multiple myeloma. | Cell Commun Signal | 2025 | 40140922 | PubTator, text mining | PubMed |
| SJB2-043, a USP1 Inhibitor, Suppresses A549 Cell Proliferation, Migration, and EMT via Modulation of PI3K/AKT/mTOR, MAPK, and Wnt Signaling Pathways. | Curr Issues Mol Biol | 2025 | 40136409 | PubTator, text mining | PubMed |
| Impact of DNA repair deficiency on sensitivity to antibody-drug conjugate (ADC) payloads in bladder cancer. | Bladder Cancer | 2025 | 40034244 | PubTator, text mining | PubMed |
| Mechanistic link between long noncoding RNA and stability of oncogene reveals stemness and chemoresistance of hepatocellular carcinoma. | World J Gastroenterol | 2025 | 39991677 | PubTator, text mining | PubMed |
| Targeting USP1 Potentiates Radiation-Induced Type I IFN-Dependent Antitumor Immunity by Enhancing Oligo-Ubiquitinated SAR1A-Mediated STING Trafficking and Activation. | Adv Sci (Weinh) | 2025 | 39976106 | PubTator, text mining | PubMed |
| Comparative analysis of chromatin accessibility in porcine oocytes from follicles of different sizes. | Res Vet Sci | 2025 | 39908890 | PubTator, text mining | PubMed |
| Recent advances in small molecule inhibitors of deubiquitinating enzymes. | Eur J Med Chem | 2025 | 39908798 | PubTator, text mining | PubMed |
| Research progress in DNA damage response (DDR)-targeting modulators: From hits to clinical candidates. | Eur J Med Chem | 2025 | 39908794 | PubTator, text mining | PubMed |
| Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 Inhibitors. | J Med Chem | 2025 | 39902599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7398/papers?page=5